AzTrials
AzTrials

AstigmatismT-IOLNCT02412215

Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients

A study testing Phacoemulsification with toric Nanoflex IOL implantation and NanoFlex toric Intraocular Lens in people with Astigmatism, run by University of Turin, Italy at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to assess the rotational stability of the new collameric Nanoflex toric intraocular lens (T-IOL) by STAAR inserted in astigmatic patients after cataract surgery. The purpose of this study is also to determine whether the use of a toric intraocular lens (T-IOL) improves visual acuity. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Astigmatism
What is being tested?
Phacoemulsification with toric Nanoflex IOL implantation and NanoFlex toric Intraocular Lens
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteItaly
Study dates
Mar 2015to Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients of 60 years of age ore more
  • Cataract
  • Corneal astigmatism of 1 diopter (D) or more

Who cannot join

  • Primary or secondary pathological conditions of the cornea
  • Zonular fibres pathologies (phacodonesis, pseudoexfoliation syndrome)
  • Irregular astigmatism (corneal scar, keratoconus, pterygium)
  • Traumatic cataract
  • Previous ocular surgery
  • Complications during cataract surgery

Trial locations and contacts

1 site in 1 country.

Antonio M Fea, MD, PhD contact

+39 011 566 6039

antoniomfea@gmail.com

Italy1 site, 1 recruiting
  • Ophthalmology Institute, University of Turin

    Turin, 10138

    Antonio M Fea, MD, PhD, +39 011 566 6039, antoniomfea@gmail.com

    Recruiting

Other trials in Italy

About this study

Official title: Rotational Stability After Nanoflex Collamer Toric Intraocular Lens Implantation in Astigmatic Patients Undergoing Cataract Surgery

This study aims to assess the rotational stability of the new collameric Nanoflex toric intraocular lens (T-IOL) by STAAR inserted in astigmatic patients after cataract surgery.

The purpose of this study is also to determine whether the use of a toric intraocular lens (T-IOL) improves visual acuity.

Read the detailed description

A good rotational stability of toric intraocular lenses (T-IOL) allows an accurate refractive correction. However, many aspects -both pre-operative and post-operative- can interfere causing T-IOL rotation and misalignment.

Complete preoperative ocular evaluation is performed including slit-lamp examination, uncorrected distance visual acuity (UDVA), best-corrected visual acuity (BCVA), Javal keratometry, corneal Scheimplug tomography (Pentacam), optical biometry (IOL Master), Goldman applanation tonometry and fundus evaluation through dilated pupils. The spherical IOL power is calculated considering the axial length obtained with optical biometry, the magnitude of astigmatism derived from Javal keratometry and the steepest axis obtained with corneal tomography. The power of the toric IOL is determined with the online Staar Toric IOL calculator. The reference landmarks are also marked preoperatively with a sterile methylene blue fine point pen. The marking is rechecked in the operating theatre with the electronic toric marker ASICO.

Postoperative evaluation for IOL alignment and rotational stability is performed with slit-lamp photography on dilated pupils. Images are captured with Haag Streit slit lamp BQ 900 and are evaluated with the image-analysis software Protractor (Staar).

Conditions
Astigmatism
Being tested
Phacoemulsification with toric Nanoflex IOL implantation, NanoFlex toric Intraocular Lens
Medical subject headings
Astigmatism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Phacoemulsification with toric Nanoflex IOL implantationProcedure or surgery

    A self-sealing incision is made with a 2.2mm knife at 110°. Phacoemulsification is performed. The foldable nanoFlex toric IOL is injected in the capsular bag using the nanoPoint single-use injector system (STAAR) or 1620 sofTip Injector (ASICO). The IOL is rotated to align the cylinder axis with the steep corneal meridian using Z align function by Callisto Eye. Every movement of the IOL axis marks are noted.

  • NanoFlex toric Intraocular LensDevice

Study groups in NCT02412215
Study groupRoleWhat they receive
Toric Nanoflex IOLExperimentalPhacoemulsification with toric Nanoflex IOL implantation
Receives: Procedure: Phacoemulsification with toric Nanoflex IOL implantation; Device: NanoFlex toric Intraocular Lens

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in rotational stability of the toric intraocular lens (T-IOL).

    The misalignment of the lens is defined as the difference (Δ) between the intended axis and the actual axis of the new collameric Nanoflex T-IOL by STAAR.

    Measured: Change of rotational stability at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months and 18 months after surgery.

Secondary outcomes (1)
  1. Correction of the astigmatism.

    Effective correction evaluated through corrected distance visual acuity (CDVA) and uncorrected distance visual acuity (UDVA).

    Measured: Change in visual acuity at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months and 18 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2015 (estimated)
  2. Study startMar 2015
  3. Primary completionMar 2017 (estimated)
  4. Study completionSep 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02412215
Sponsor's protocol ID
0026769
Acronym
T-IOL
Status last verified
Apr 2015
First submitted
29 Mar 2015
Last updated
9 Apr 2015
Results posted
No
Data monitoring committee
No

Publications

  • Ferrer-Blasco T, Montes-Mico R, Peixoto-de-Matos SC, Gonzalez-Meijome JM, Cervino A. Prevalence of corneal astigmatism before cataract surgery. J Cataract Refract Surg. 2009 Jan;35(1):70-5. doi: 10.1016/j.jcrs.2008.09.027.

    PubMed 19101427
  • Rashad KM. Laser in situ keratomileusis for myopic astigmatism. J Refract Surg. 1999 Nov-Dec;15(6):653-60. doi: 10.3928/1081-597X-19991101-09.

    PubMed 10590003
  • Novis C. Astigmatism and toric intraocular lenses. Curr Opin Ophthalmol. 2000 Feb;11(1):47-50. doi: 10.1097/00055735-200002000-00007.

    PubMed 10724827
  • Chang DF. Early rotational stability of the longer Staar toric intraocular lens: fifty consecutive cases. J Cataract Refract Surg. 2003 May;29(5):935-40. doi: 10.1016/s0886-3350(02)01843-6.

    PubMed 12781279
  • Lane SS, Burgi P, Milios GS, Orchowski MW, Vaughan M, Schwarte E. Comparison of the biomechanical behavior of foldable intraocular lenses. J Cataract Refract Surg. 2004 Nov;30(11):2397-402. doi: 10.1016/j.jcrs.2004.03.041.

    PubMed 15519095
  • Lombardo M, Carbone G, Lombardo G, De Santo MP, Barberi R. Analysis of intraocular lens surface adhesiveness by atomic force microscopy. J Cataract Refract Surg. 2009 Jul;35(7):1266-72. doi: 10.1016/j.jcrs.2009.02.029.

    PubMed 19545819
  • Lane SS, Ernest P, Miller KM, Hileman KS, Harris B, Waycaster CR. Comparison of clinical and patient-reported outcomes with bilateral AcrySof toric or spherical control intraocular lenses. J Refract Surg. 2009 Oct;25(10):899-901. doi: 10.3928/1081597X-20090617-05. Epub 2009 Oct 12.

    PubMed 19835331
  • Koshy JJ, Nishi Y, Hirnschall N, Crnej A, Gangwani V, Maurino V, Findl O. Rotational stability of a single-piece toric acrylic intraocular lens. J Cataract Refract Surg. 2010 Oct;36(10):1665-70. doi: 10.1016/j.jcrs.2010.05.018.

    PubMed 20870111
  • Entabi M, Harman F, Lee N, Bloom PA. Injectable 1-piece hydrophilic acrylic toric intraocular lens for cataract surgery: efficacy and stability. J Cataract Refract Surg. 2011 Feb;37(2):235-40. doi: 10.1016/j.jcrs.2010.08.040.

    PubMed 21241904
  • Visser N, Bauer NJ, Nuijts RM. Toric intraocular lenses: historical overview, patient selection, IOL calculation, surgical techniques, clinical outcomes, and complications. J Cataract Refract Surg. 2013 Apr;39(4):624-37. doi: 10.1016/j.jcrs.2013.02.020.

    PubMed 23522584
  • Shimizu K, Misawa A, Suzuki Y. Toric intraocular lenses: correcting astigmatism while controlling axis shift. J Cataract Refract Surg. 1994 Sep;20(5):523-6. doi: 10.1016/s0886-3350(13)80232-5.

    PubMed 7996408
  • Till JS, Yoder PR Jr, Wilcox TK, Spielman JL. Toric intraocular lens implantation: 100 consecutive cases. J Cataract Refract Surg. 2002 Feb;28(2):295-301. doi: 10.1016/s0886-3350(01)01035-5.

    PubMed 11821213
  • Dick HB, Krummenauer F, Trober L. [Compensation of corneal astigmatism with toric intraocular lens: results of a multicentre study]. Klin Monbl Augenheilkd. 2006 Jul;223(7):593-608. doi: 10.1055/s-2006-926652. German.

    PubMed 16855943
  • Stewart CM, McAlister JC. Comparison of grafted and non-grafted patients with corneal astigmatism undergoing cataract extraction with a toric intraocular lens implant. Clin Exp Ophthalmol. 2010 Nov;38(8):747-57. doi: 10.1111/j.1442-9071.2010.02336.x.

    PubMed 20497428
  • Chang DF. Comparative rotational stability of single-piece open-loop acrylic and plate-haptic silicone toric intraocular lenses. J Cataract Refract Surg. 2008 Nov;34(11):1842-7. doi: 10.1016/j.jcrs.2008.07.012.

    PubMed 19006728

Questions about this trial

What is this clinical trial studying?

A study testing Phacoemulsification with toric Nanoflex IOL implantation and NanoFlex toric Intraocular Lens in people with Astigmatism, run by University of Turin, Italy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Antonio M Fea, MD, PhD (+39 011 566 6039, antoniomfea@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in rotational stability of the toric intraocular lens (T-IOL). (time frame: Change of rotational stability at 1 day, 1 week, 1 month, 3 months, 6 months, 12 months and 18 months after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02412215, which also lists 33 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in